Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors

Published:2001-09 Issue:18 Volume:8 Page:1416-1426
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Wu L,Matherly J,Smallwood A,Adams J Yeates,Billick E,Belldegrun A,Carey M

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301549.pdf

Reference53 articles.

1. Landis SH, Murray T, Bolden S, Wingo PA . Cancer statistics, 1999 CA Cancer J Clin 1999 49: 8–31

2. Aumuller G et al. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles Prostate 1990 17: 31–40

3. Catalona WJ et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 1991 324: 1156–1161

4. Young CY, Andrews PE, Montgomery BT, Tindall DJ . Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein Biochemistry 1992 31: 818–824

5. Schuur ER et al. Prostate-specific antigen expression is regulated by an upstream enhancer J Biol Chem 1996 271: 7043–7051

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy and Gene Editing for Cancer Therapeutics;Research Anthology on Bioinformatics, Genomics, and Computational Biology;2023-12-29

2. Applications of tissue-specific and cancer-selective gene promoters for cancer diagnosis and therapy;Advances in Cancer Research;2023

3. Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy;Journal for ImmunoTherapy of Cancer;2021-10

4. Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner;Molecular & Cellular Proteomics;2021

5. Gene Therapy and Gene Editing for Cancer Therapeutics;Handbook of Research on Advancements in Cancer Therapeutics;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3